In the present study, Ang II treatment increased the size and weight of lymphoma in nude mice, but AT1R antagonist losartan significantly inhibited this trend in nude mice intraperitoneally injected with NK/T-cell lymphoma cells. This evidence concerns the gene AGT and T-cell non-Hodgkin lymphoma.